MINJUVI 200 mg powder for concentrate for solution for infusion

Active Ingredient
Strength
  • Tafasitamab: 200 mg
Dosage Form
Powder for concentrate for Solution for infusion
Legal Category
C - restricted prescription
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/21/1570/001 200 mg L01FX12 Powder for concentrate for Solution for infusion
Licence number
EU/1/21/1570/001
Strength
200 mg
ATC Code
L01FX12
Dosage Form
Powder for concentrate for Solution for infusion

Incyte Biosciences UK Ltd

First Floor Q1, The Square, Randalls Way, Leatherhead, KT22 7TW

Telephone
+80000027423